hSNCA(2)
Nomenclature
C57BL/6JSmo-Sncatm1(hSNCA)Smoc
Cat. NO.
NM-HU-251485
Strain State
Repository Live
Gene Summary
Gene Symbol
Snca
Model Description
Validation Data

Fig.1 Detection of SNCA expression in WT mice and hSNCA(2) mice by WB. α-synuclein (SNCA) was detectable at a similar level in hippocampus and cortex from both WT C57BL/6 and HE hSNCA(2) mice with an antibody which is cross-reactived between human and mouse SNCA. The hippocampus and cortex lysates were collected from 12-week-old female WT C57BL/6 mice and 7-week-old male heterozygous hSNCA(2) mice, and then analyzed by western blot with an anti-human/mouse SNCA antibody.
Abbr. HE, heterozygous; WT, wild type. M, marker.

Fig.2 Detection of human SNCA expression in WT mice and hSNCA(2) mice by WB. Human α-synuclein (SNCA) was exclusively detectable in hippocampus and cortex from HE hSNCA(2) mice with a human SNCA-specific antibody. The hippocampus and cortex tissue lysates were collected from 12-week-old female WT C57BL/6 mice and 7-week-old male heterozygous hSNCA(2) mice, and then analyzed by western blot with an anti-human SNCA antibody.
Abbr. HE, heterozygous; WT, wild type; M, marker.

Fig.3 Detection of SNCA expression in heart, pancreas, small intestine and frontal lobe by RT-PCR. Mouse Snca mRNA (168 bp) was detectable only in wild-type C57BL/6 mice. Human SNCA mRNA (120 bp) was detectable only in homozygous hSNCA(2) knockin mice but not in wild-type mice. Heart, pancreas, small intestine and frontal lobe RNA was extracted from 7-week-old female wild-type C57BL/6 mice (n=2) and homozygous hSNCA(2) knockin mice (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers.
Abbr. M, marker; HO, homozygous; WT, wild type.
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more